Genmab

Prezzo Delle Azioni
1,871.00
Cambio Giornaliero
-33.50 -1.76%
Mensile
-8.42%
Annuale
23.95%
Q1 Previsione
1,806.42




Ebit Cambiamento Data
Agios Pharmaceuticals USD -121.58M 4.71M 2025-12
Almirall EUR 43.02M 28.78M 2025-06
Amarin USD -1.7M 8.47M 2025-09
Amgen USD 3.96B 464M 2025-12
argenx SE USD 349.97M 61.94M 2025-09
AstraZeneca USD 2.97B 4.48B 2025-12
Bayer EUR -399M 363M 2025-09
BioMarin Pharmaceutical USD -31.69M 308.58M 2025-09
Demant DKK 2.07B 201M 2025-12
Exelixis USD 235.91M 20.45M 2025-12
Fresenius Medical Care EUR 449.94M 18.94M 2025-09
Galapagos EUR -41.67M 15.35M 2025-09
Genmab DKK 432M 900.27M 2025-06
GlaxoSmithKline GBP 1.44B 1.35B 2025-12
GN Store Nord DKK 570M 230M 2025-12
GRIFOLS EUR 352.11M 20.18M 2025-09
Hikma Pharmaceutical USD 317M 85M 2024-12
Insmed USD -261.35M 7.48M 2025-09
Lonza CHF 673M 54M 2025-06
Merck EUR 1.21B 180M 2025-09
Novartis USD -9.19B 13.87B 2025-06
Regeneron Pharmaceuticals USD 898.6M 211.3M 2025-12
Roche Holding CHF 9.56B 2.1B 2025-12
Sanofi EUR 1.7B 2.17B 2025-12
UCB EUR 502M 168M 2024-12


Genmab - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.